Cargando…
Pathogenetic and clinical study of a patient with thrombocytopenia due to the p.E527K gain-of-function variant of SRC
Autores principales: | Barozzi, Serena, Di Buduo, Christian A., Marconi, Caterina, Bozzi, Valeria, Seri, Marco, Romano, Francesca, Balduini, Alessandra, Pecci, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927995/ https://www.ncbi.nlm.nih.gov/pubmed/33054137 http://dx.doi.org/10.3324/haematol.2020.268516 |
Ejemplares similares
-
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup
por: Marconi, Caterina, et al.
Publicado: (2022) -
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
por: Pecci, Alessandro, et al.
Publicado: (2017) -
Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial
por: Zaninetti, Carlo, et al.
Publicado: (2020) -
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines
por: Panza, Emanuele, et al.
Publicado: (2008) -
Combined transcriptome and proteome profiling of SRC kinase activity in healthy and E527K defective megakaryocytes
por: De Kock, Lore, et al.
Publicado: (2021)